Target intelligence / Profile preview

N-myc downstream regulated gene 1 protein (NDRG1)

Target
NDRG1
Molecular classification
Other (member of the NDRG/alpha/beta hydrolase family, but NDRG1 lacks catalytic hydrolase activity)
01

Overview

The N-myc downstream regulated gene 1 protein (NDRG1) is a cytoplasmic and, under stress, nuclear protein involved in cellular stress response, cell proliferation, differentiation, vesicular trafficking, and apoptosis. NDRG1 acts as a tumor suppressor in multiple cancers by inhibiting proliferation and metastasis, and is crucial for Schwann cell myelination. It is implicated in hypoxia adaptation and is upregulated by stress, particularly hypoxia and certain metals. Mutations in NDRG1 are causative for Charcot-Marie-Tooth disease type 4D, a demyelinating neuropathy. NDRG1 influences pathways including p53-mediated apoptosis, PI3K, c-Src, and WNT signaling, and stabilizes DNA repair proteins such as MGMT. Its expression and subcellular localization are highly responsive to environmental and metabolic stressors

Other names
Protein NDRG1CAP43DRG1RTPDRG-1TDD5NDR1Differentiation-related gene 1 proteinNickel-specific induction protein Cap43Reducing agents and tunicamycin-responsive proteinRit42CMT4DGC4HMSNLNMSLPROXY1RIT42TARG1
02

Mechanism of action

Not established for direct-acting drugs. Some mechanisms for experimental modulation include inhibition of hypoxia-regulated pathways or induction via heavy metal exposure (e.g., nickel, cobalt) or regulation through tumor suppressor signaling (e.g., p53)

03

Biological functions

Stress response (hypoxia, metabolic, cellular)Cell proliferationCell differentiationApoptosisMetabolismCell deathLipid biosynthesis, transportVesicular trafficking/endosomal recyclingDNA repairRegulation of cell adhesion and motilityMyelination (in Schwann cells/pns)
04

Disease associations

Cancer (tumor/metastasis suppressor in multiple cancers)Peripheral neuropathy (especially Charcot-Marie-Tooth disease type 4D)Neurodegenerative diseaseInflammation (role in immune response)Other (involved in aging, hypoxia adaptation)
05

Safety considerations

No known specific safety concerns for therapeutic intervention due to limited direct targeting; loss of function causes neuropathy
06

Interacting drugs

None established for direct clinical targeting; several pathways (e.g., PI3K, c-Src, RAS) and experimental agents affect NDRG1 expression, but no clinically approved drugs are known to directly target NDRG1
07

Biomarkers

Expression of NDRG1 is a prognostic biomarker in several cancersMutations are diagnostic for Charcot-Marie-Tooth disease type 4D

Beyond the preview

Go deeper on N-myc downstream regulated gene 1 protein (NDRG1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-myc downstream regulated gene 1 protein (NDRG1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call